These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neutral antibodies to the TSH receptor are present in Graves' disease and regulate selective signaling cascades. Morshed SA; Ando T; Latif R; Davies TF Endocrinology; 2010 Nov; 151(11):5537-49. PubMed ID: 20844004 [TBL] [Abstract][Full Text] [Related]
3. How one TSH receptor antibody induces thyrocyte proliferation while another induces apoptosis. Morshed SA; Ma R; Latif R; Davies TF J Autoimmun; 2013 Dec; 47():17-24. PubMed ID: 23958398 [TBL] [Abstract][Full Text] [Related]
4. Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding. Dallas JS; Cunningham SJ; Patibandla SA; Seetharamaiah GS; Morris JC; Tahara K; Kohn LD; Prabhakar BS Endocrinology; 1996 Aug; 137(8):3329-39. PubMed ID: 8754759 [TBL] [Abstract][Full Text] [Related]
5. A Gq Biased Small Molecule Active at the TSH Receptor. Latif R; Morshed SA; Ma R; Tokat B; Mezei M; Davies TF Front Endocrinol (Lausanne); 2020; 11():372. PubMed ID: 32676053 [TBL] [Abstract][Full Text] [Related]
6. A human monoclonal autoantibody to the thyrotropin receptor with thyroid-stimulating blocking activity. Sanders J; Evans M; Betterle C; Sanders P; Bhardwaja A; Young S; Roberts E; Wilmot J; Richards T; Kiddie A; Small K; Platt H; Summerhayes S; Harris R; Reeve M; Coco G; Zanchetta R; Chen S; Furmaniak J; Smith BR Thyroid; 2008 Jul; 18(7):735-46. PubMed ID: 18631002 [TBL] [Abstract][Full Text] [Related]
8. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation. Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757 [TBL] [Abstract][Full Text] [Related]
9. Regulation of the phosphatidylinositol 3-kinase, Akt/protein kinase B, FRAP/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid gland. Suh JM; Song JH; Kim DW; Kim H; Chung HK; Hwang JH; Kim JM; Hwang ES; Chung J; Han JH; Cho BY; Ro HK; Shong M J Biol Chem; 2003 Jun; 278(24):21960-71. PubMed ID: 12668683 [TBL] [Abstract][Full Text] [Related]
10. Involvement of the protein kinase C pathway in thyrotropin-induced STAT3 activation in FRTL-5 thyroid cells. Park YJ; Park ES; Kim MS; Kim TY; Lee HS; Lee S; Jang IS; Shong M; Park DJ; Cho BY Mol Cell Endocrinol; 2002 Aug; 194(1-2):77-84. PubMed ID: 12242030 [TBL] [Abstract][Full Text] [Related]
11. TSH receptor antibodies do not alter the function of gonadotropin receptors stably expressed in eukaryotic cells. Tonacchera M; Ferrarini E; Dimida A; Agretti P; De Marco G; De Servi M; Chiovato L; Cetani F; Vitti P; Pinchera A Eur J Endocrinol; 2004 Mar; 150(3):381-7. PubMed ID: 15012625 [TBL] [Abstract][Full Text] [Related]
12. Graves' immunoglobulins activate phospholipase A2 by recognizing specific epitopes on thyrotropin receptor. Di Cerbo A; Di Paola R; Menzaghi C; De Filippis V; Tahara K; Corda D; Kohn LD J Clin Endocrinol Metab; 1999 Sep; 84(9):3283-92. PubMed ID: 10487700 [TBL] [Abstract][Full Text] [Related]
13. Characterization of monoclonal thyroid-stimulating and thyrotropin binding-inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid disease. Kohn LD; Suzuki K; Hoffman WH; Tombaccini D; Marcocci C; Shimojo N; Watanabe Y; Amino N; Cho BY; Kohno Y; Hirai A; Tahara K J Clin Endocrinol Metab; 1997 Dec; 82(12):3998-4009. PubMed ID: 9398703 [TBL] [Abstract][Full Text] [Related]